Insider Transactions in Q4 2024 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 05
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-8.31%
|
$18,000,000
$30.3 P/Share
|
|
Nov 05
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
600,000
-9.02%
|
$18,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Valor Iv Pharma Holdings, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-35.66%
|
$120,000,000
$30.3 P/Share
|
|
Nov 01
2024
|
Marshman Fund Trust Ii > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,000,000
-37.55%
|
$120,000,000
$30.3 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
21,496
-100.0%
|
$859,840
$40.47 P/Share
|
|
Oct 29
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
21,496
+50.0%
|
$515,904
$24.0 P/Share
|
|
Oct 03
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
36,357
-99.03%
|
$1,272,495
$35.33 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
400
-100.0%
|
$16,000
$40.19 P/Share
|
|
Oct 01
2024
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+50.0%
|
$9,600
$24.0 P/Share
|